A flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales in 2023. Read more
Tag: Moderna
Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and lowered full-year sales guidance by up to $3 billion. The stock was last Read more
Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in Read more
Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in Read more
Moderna stock slides 14% premarket after profit and revenue fall short of estimates and biotech offers soft guidance
Moderna Inc. shares MRNA, -3.88% slid 14% in premarket trade Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and said short-term supply constraints would impact 2022 advance Read more
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age. The Read more
Pfizer and BioNTech seek authorization of omicron-targeted booster for children aged 5 to 11
Pfizer and German partner BioNTech said Monday they’re seeking Food and Drug Administration authorization for their omicron-targeting bivalent vaccine for use in children 5 to 11 years of age. The Read more
Moderna expects the shortage of its updated COVID-19 booster to soon be resolved
Moderna Inc. MRNA, -0.40% said Wednesday that it expects to resolve supply issues for its new COVID-19 booster “in the coming days.” Several media outlets reported this week that a Read more
Moderna expects the shortage of its updated COVID-19 booster to soon be resolved
Moderna Inc. MRNA, -0.74% said Wednesday that it expects to resolve supply issues for its new COVID-19 booster “in the coming days.” Several media outlets reported this week that a Read more
Vaccine stocks Pfizer, BioNTech, Moderna and Novavax slide after Biden says pandemic is over
Stocks of the three key vaccine makers fell sharply Monday, after President Joe Biden said the pandemic is over, in an interview with “60 Minutes” that aired on Sunday. Moderna Read more
- 1
- 2